• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archive by Topic » News

Updated FDA Guidance for Blood Donor Eligibility for Blood Pressure and Pulse

The U.S. Food and Drug Administration (FDA) has previously provided guidance for the eligibility of blood donors with blood pressure…

July 30, 2024

Carnitine Metabolism Associated with Red Blood Cell Hemolysis

Red blood cells can be stored up to 42 days, after which they progressively develop a series of storage lesions—partly…

July 25, 2024

No Transfusion-Transmission of Classic Creutzfeldt-Jakob Disease

Classic Creutzfeldt-Jakob disease (CJD) is a rare and fatal neurodegenerative spongiform encephalopathy caused by prions (i.e., misfolded proteins). First recognized…

July 17, 2024

RBC Transfusions Guidelines for Very Preterm Infants

Most clinical practice guidelines for blood transfusion have focused on adults and limited recommendations are available for children and neonates….

July 9, 2024

Ferritin-Guided Blood Donations Protect Iron Stores in Donors

In both North America and Europe, whole blood donors are eligible to donate whole blood every 56 days. Donors lose…

July 3, 2024

Donor Deferral Model Evaluates Impact of New Individual Risk Assessment

When AIDS emerged in the early 1980s, the risk of acquiring HIV from a transfusion was approximately 1.1%. The U.S….

June 28, 2024

Liberal versus Restrictive Transfusion Strategy for Patients with Traumatic Brain Injury and Anemia

While a restrictive RBC transfusion strategy has been shown to be safe and effective for most patients, there is uncertainty…

June 19, 2024

Luspatercept Reduces Transfusion-Dependence for Anemic Patients with Myelofibrosis

Myelofibrosis is a rare bone marrow cancer characterized by excessive scarring that disrupts the production of red blood cells. Current…

June 11, 2024

FDA: Donor Screening of Zika Virus Unnecessary in United States

In 2015 and 2016, large outbreaks of the mosquito-borne Zika virus occurred in the Americas.  Infection with the Zika virus…

June 5, 2024

Tranexamic Acid Treatment Does Not Reduce Hematoma Growth in Patients with Intracerebral Hemorrhage

Intracerebral hemorrhage affects approximately 3.4 million individuals worldwide annually. Hematoma growth during intracerebral hemorrhage is associated with significant morbidity and…

May 29, 2024

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Interim pages omitted …
  • Page 62
  • Go to Next Page »

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley